In Depth 24 Apr 2024
Overcoming toxicities: are IL-2 smart cytokines the next big thing?
A more advanced form of IL-2 cytokine therapy called IL-2 smart cytokines could overcome side effects, and shake up cancer care as we know it.
Immunotherapy
- Latest Posts
Best in Biotech 14 Mar 2024
7 oncolytic virus companies you should know about
Find out more about 7 oncolytic virus companies advancing their drug candidates through clinical trials to help cancer patients.
Best in Biotech 13 Feb 2024
Eight biotechs thriving in Seattle
In this article, let us take a look at some of the major biotech companies in Seattle that are contributing to the biotech industry at large.
In Depth 5 Feb 2024
Future of cancer treatment: what will therapy look like in 2034?
From groundbreaking immunotherapies to AI diagnostics and new vaccines, explore the innovations shaping the future of cancer treatment.
Best in Biotech 30 Jan 2024
Navigating German biotech: 13 key players to know
The German biotech ecosystem is well established despite the challenges it is facing. Discover thirteen key Germany-based biotech companies.
Best in Biotech 23 Jan 2024
19 French biotechs you should know about
France is at the forefront of innovative biotech and Paris has become a vibrant startup ecosystem. Here are 19 top French biotech companies!
ADVERTISEMENT
ADVERTISEMENT
In Depth 15 Jan 2024
The future of diabetes treatment: Is a cure possible?
Diabetes has become an epidemic. Science is striving to find a diabetes treatment that can cure this chronic disease, but how close are we?
More News! 4 Dec 2023
FDA CAR-T cell therapy warning: Are T cells malignant?
Chimeric antigen receptor (CAR) T cell therapies have emerged as groundbreaking treatments for various hematologic cancers, demonstrating remarkable efficacy in targeting specific cancer cells. However, recent concerns raised by the U.S. Food and Drug Administration (FDA) have sparked an investigation into potential risks associated with these therapies. The FDA CAR-T cell therapy warning comes at […]
In Depth 30 Nov 2023
Could an Alzheimer’s vaccine make treatment more affordable?
Alzheimer’s research has come a long way since the disease was first identified more than a century ago. Now, as treatments have been developed to reduce the harmful proteins in the brain that are associated with Alzheimer’s, vaccine trials are underway to eliminate these proteins. But how far along are these vaccines in the clinic? […]
In Depth 23 Nov 2023
The next frontier in immunotherapy? CAR-Macrophages as a novel cancer treatment strategy
Immunotherapy has revolutionized cancer treatment, offering promising avenues beyond traditional methods. Recent breakthroughs showcased at the Society for Immunotherapy of Cancer’s (SITC) annual meeting have spotlighted innovative approaches, notably chimeric antigen receptor macrophage (CAR-M) therapy, offering new strategies in the fight against solid tumors and addressing the limitations of current treatments. Navigating the labyrinth: immunotherapy’s […]
Best in Biotech 21 Nov 2023
Beyond insulin: six cutting-edge diabetes biotech companies you should know about
As we predicted last year, the diabetes market is booming, particularly after the incredible success of new diabetes drugs like Novo Nordisk’s Ozempic and Eli Lilly’s Mounjaro. There are now several diabetes biotech companies that are garnering attention, all with their own innovative solutions to tackling both type 1 and type 2 diabetes. The prevalence […]
In Depth 12 Oct 2023
Can immunometabolism-based therapies transform the way cancers and autoimmune diseases are treated?
The immune system protects our bodies from foreign invaders, but sometimes, when it malfunctions, it can result in life-threatening autoimmune disorders. But what if the immune system could be regulated to counter these diseases? Immunometabolism, an emerging field in therapeutics, aims to rein in autoimmunity altogether. According to Neil Weir, chief executive officer (CEO) of […]
ADVERTISEMENT